|
COFCO Biotechnology Co., Ltd. (000930.SZ) DCF Valuation
CN | Basic Materials | Chemicals - Specialty | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
COFCO Biotechnology Co., Ltd. (000930.SZ) Bundle
Streamline your analysis and improve precision with our (000930SZ) DCF Calculator! With access to real COFCO Biotechnology Co., Ltd. data and customizable assumptions, this tool empowers you to forecast, analyze, and value COFCO Biotechnology like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19,472.0 | 19,909.4 | 23,468.6 | 19,918.1 | 20,379.0 | 20,751.3 | 21,130.5 | 21,516.5 | 21,909.7 | 22,310.0 |
| Revenue Growth, % | 0 | 2.25 | 17.88 | -15.13 | 2.31 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 |
| EBITDA | 1,253.7 | 1,332.7 | 1,985.0 | 1,905.2 | 62.1 | 1,305.7 | 1,329.5 | 1,353.8 | 1,378.6 | 1,403.8 |
| EBITDA, % | 6.44 | 6.69 | 8.46 | 9.57 | 0.30464 | 6.29 | 6.29 | 6.29 | 6.29 | 6.29 |
| Depreciation | 445.1 | 462.1 | 470.6 | 476.1 | 491.8 | 473.8 | 482.5 | 491.3 | 500.2 | 509.4 |
| Depreciation, % | 2.29 | 2.32 | 2.01 | 2.39 | 2.41 | 2.28 | 2.28 | 2.28 | 2.28 | 2.28 |
| EBIT | 808.7 | 870.5 | 1,514.4 | 1,429.1 | -429.8 | 831.9 | 847.1 | 862.6 | 878.3 | 894.4 |
| EBIT, % | 4.15 | 4.37 | 6.45 | 7.17 | -2.11 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 |
| Total Cash | 700.5 | 662.3 | 1,116.0 | 1,016.6 | 1,481.1 | 998.2 | 1,016.4 | 1,035.0 | 1,053.9 | 1,073.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 975.1 | 1,461.7 | 1,188.8 | 1,369.9 | 1,123.5 | 1,237.0 | 1,259.6 | 1,282.6 | 1,306.1 | 1,329.9 |
| Account Receivables, % | 5.01 | 7.34 | 5.07 | 6.88 | 5.51 | 5.96 | 5.96 | 5.96 | 5.96 | 5.96 |
| Inventories | 2,770.0 | 4,991.5 | 4,052.3 | 3,763.2 | 2,534.3 | 3,647.8 | 3,714.4 | 3,782.3 | 3,851.4 | 3,921.8 |
| Inventories, % | 14.23 | 25.07 | 17.27 | 18.89 | 12.44 | 17.58 | 17.58 | 17.58 | 17.58 | 17.58 |
| Accounts Payable | 854.8 | 845.8 | 920.2 | 919.6 | 766.5 | 869.0 | 884.8 | 901.0 | 917.5 | 934.2 |
| Accounts Payable, % | 4.39 | 4.25 | 3.92 | 4.62 | 3.76 | 4.19 | 4.19 | 4.19 | 4.19 | 4.19 |
| Capital Expenditure | -900.8 | -987.5 | -1,109.8 | -565.8 | -634.5 | -841.2 | -856.6 | -872.2 | -888.2 | -904.4 |
| Capital Expenditure, % | -4.63 | -4.96 | -4.73 | -2.84 | -3.11 | -4.05 | -4.05 | -4.05 | -4.05 | -4.05 |
| Tax Rate, % | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 | -11.48 |
| EBITAT | 719.5 | 643.8 | 1,236.8 | 1,112.4 | -479.1 | 702.8 | 715.7 | 728.8 | 742.1 | 755.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,626.5 | -2,598.7 | 1,884.1 | 1,130.1 | 700.5 | -789.1 | 268.2 | 273.1 | 278.1 | 283.1 |
| WACC, % | 5.51 | 5.33 | 5.43 | 5.38 | 5.65 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 167.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 289 | |||||||||
| Terminal Value | 8,349 | |||||||||
| Present Terminal Value | 6,400 | |||||||||
| Enterprise Value | 6,568 | |||||||||
| Net Debt | 2,280 | |||||||||
| Equity Value | 4,288 | |||||||||
| Diluted Shares Outstanding, MM | 1,842 | |||||||||
| Equity Value Per Share | 2.33 |
What You Will Gain
- Pre-Filled Financial Model: COFCO Biotechnology’s actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
- Real-Time Calculations: Automatic updates allow you to view results instantly as adjustments are made.
- Professional-Quality Template: A polished Excel file crafted for high-standard valuation analysis.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasting.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for COFCO Biotechnology Co., Ltd. (000930SZ).
- WACC Calculator: Pre-built Weighted Average Cost of Capital template with adjustable parameters to fit your needs.
- Customizable Forecast Assumptions: Adjust growth projections, capital expenses, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for COFCO Biotechnology Co., Ltd. (000930SZ).
- Interactive Dashboard and Charts: Visual representations highlighting essential valuation metrics for straightforward analysis.
How It Functions
- 1. Access the Template: Download and launch the Excel file containing COFCO Biotechnology Co., Ltd.'s (000930SZ) preloaded data.
- 2. Modify Assumptions: Adjust critical inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation scenarios.
- 5. Present with Assurance: Share professional valuation analyses to strengthen your decision-making.
Why Opt for COFCO Biotechnology Co., Ltd. (000930SZ) Calculator?
- Designed for Experts: A sophisticated tool crafted for biotechnologists, financial analysts, and industry consultants.
- Authentic Data: COFCO's historical and anticipated financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions.
- Concise Results: Instantly computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Can Benefit from Our Product?
- Biotechnology Students: Discover innovative research methods and apply them using real-world data.
- Researchers: Integrate advanced biotechnological models into your studies or publications.
- Investors: Evaluate your investment strategies and scrutinize the performance metrics for COFCO Biotechnology Co., Ltd. (000930SZ).
- Industry Analysts: Enhance your analysis with a ready-to-use, customizable biotechnological evaluation model.
- Entrepreneurs: Understand how major biotechnology firms like COFCO navigate the industry landscape.
Contents of the Template
- Pre-Filled DCF Model: COFCO Biotechnology's financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess COFCO Biotechnology's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your forecasts.
- Financial Statements: Access annual and quarterly reports to facilitate in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.